Free Trial

CRISM Therapeutics (CRTX) Competitors

GBX 10.90 +1.40 (+14.74%)
As of 03:22 AM Eastern

CRTX vs. ARV, LND, VAST, CLA, CTL, GLR, CRTM, BZT, TGR, and BMV

Should you be buying CRISM Therapeutics stock or one of its competitors? The main competitors of CRISM Therapeutics include Artemis Resources (ARV), Landore Resources (LND), Vast Resources (VAST), Celsius Resources (CLA), CleanTech Lithium (CTL), Galileo Resources (GLR), Critical Metals (CRTM), Bezant Resources (BZT), Tirupati Graphite (TGR), and Bluebird Merchant Ventures (BMV). These companies are all part of the "other industrial metals & mining" industry.

CRISM Therapeutics vs. Its Competitors

Artemis Resources (LON:ARV) and CRISM Therapeutics (LON:CRTX) are both small-cap basic materials companies, but which is the better investment? We will compare the two companies based on the strength of their profitability, dividends, analyst recommendations, risk, institutional ownership, earnings, media sentiment and valuation.

5.2% of Artemis Resources shares are owned by institutional investors. Comparatively, 0.3% of CRISM Therapeutics shares are owned by institutional investors. 13.0% of Artemis Resources shares are owned by company insiders. Comparatively, 97.3% of CRISM Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

CRISM Therapeutics has lower revenue, but higher earnings than Artemis Resources. CRISM Therapeutics is trading at a lower price-to-earnings ratio than Artemis Resources, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Artemis Resources£634.57K20.32-£43.80M-£0.01-38.79
CRISM Therapeutics£25K174.23-£792.20K-£0.02-605.56

In the previous week, Artemis Resources' average media sentiment score of 0.00 equaled CRISM Therapeutics'average media sentiment score.

Company Overall Sentiment
Artemis Resources Neutral
CRISM Therapeutics Neutral

CRISM Therapeutics has a net margin of 0.00% compared to Artemis Resources' net margin of -6,902.37%. CRISM Therapeutics' return on equity of -13.12% beat Artemis Resources' return on equity.

Company Net Margins Return on Equity Return on Assets
Artemis Resources-6,902.37% -42.70% -1.79%
CRISM Therapeutics N/A -13.12%-26.77%

Artemis Resources has a beta of 0.18, indicating that its stock price is 82% less volatile than the S&P 500. Comparatively, CRISM Therapeutics has a beta of 0.81, indicating that its stock price is 19% less volatile than the S&P 500.

Summary

CRISM Therapeutics beats Artemis Resources on 6 of the 11 factors compared between the two stocks.

Get CRISM Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for CRTX and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CRTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CRTX vs. The Competition

MetricCRISM TherapeuticsOther Industrial Metals & Mining IndustryMaterials SectorLON Exchange
Market Cap£4.36M£1.00B£3.66B£2.56B
Dividend YieldN/A6.12%5.06%5.33%
P/E Ratio-605.56123.29161.365,399.09
Price / Sales174.2345,636.9217,824.8297,453.95
Price / CashN/A24.7025.8927.93
Price / Book0.258.696.769.13
Net Income-£792.20K£71.69M£149.17M£5.89B
7 Day Performance3.81%4.69%3.25%0.98%
1 Month Performance5.83%16.19%12.40%3.00%
1 Year Performance9.00%71.23%47.28%191.03%

CRISM Therapeutics Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CRTX
CRISM Therapeutics
N/AGBX 10.90
+14.7%
N/A-20.0%£4.36M£25K-605.564Gap Up
ARV
Artemis Resources
N/AGBX 0.39
+2.7%
N/A-51.4%£14.76M£634.57K-33.19N/AGap Up
High Trading Volume
LND
Landore Resources
N/AGBX 3.92
-3.3%
N/A+50.8%£13.74MN/A-39,160.006Gap Up
VAST
Vast Resources
N/AGBX 0.34
+1.8%
N/A+336.8%£13.14M£446K-28.20350
CLA
Celsius Resources
N/AGBX 0.40
flat
N/A-38.3%£12.54M£647.00-67.80N/AGap Up
CTL
CleanTech Lithium
N/AGBX 5.37
+2.3%
N/A-68.4%£10.50MN/A-559.3820Gap Down
GLR
Galileo Resources
N/AGBX 0.87
+2.4%
N/A-12.3%£10.06MN/A580.001Positive News
Gap Down
High Trading Volume
CRTM
Critical Metals
N/AGBX 9.49
+2.6%
N/A+292.0%£9.03M£3.58K-24.313High Trading Volume
BZT
Bezant Resources
N/AGBX 0.05
-1.8%
N/A+103.7%£8.74MN/A-540.005
TGR
Tirupati Graphite
N/AN/AN/AN/A£8.67M£4.38M-2.4136,000
BMV
Bluebird Merchant Ventures
N/AGBX 1.08
-1.8%
N/A-1.2%£8.64MN/A-327.279

Related Companies and Tools


This page (LON:CRTX) was last updated on 9/24/2025 by MarketBeat.com Staff
From Our Partners